Biocare Medical Buys Empire Genomics
Summary
Together, Biocare Medical and Empire Genomics will bring an expanded offering of solutions to those researching and diagnosing cancer around the world. Led by CEO Luis de Luzuriaga, Biocare Medical is a provider of solutions for cancer research and diagnostics, providing: reagents, including tissue-conserving simultaneous Multiplex IHC antibody cocktails and detections; Customer Care; and a comprehensive suite of instrumentation for IHC, molecular, and histology testing. Its reagent portfolio includes primary antibodies, Multiplex IHC, and FISH probes for target indications. Biocare also offers a line of polymer detections for clinical, human, and animal research that deliver high sensitivity and exceptionally low background. The company’s automated instrument platforms, intelliPATH and ONCORE Pro, have been designed to meet every need from high throughput clinical diagnostics to flexible research requirements.